MFN2 and neuromuscular disease: While it seems likely that all of these mechanisms contribute in a combinatorial way to CMT2A neuromuscular disease, disrupted mitochondrial trafficking is particularly intriguing as a contributory mechanism because a transportation defect could explain why CMT2A preferentially affects the longest peripheral nerves innervating lower and upper limbs; travel delays have greater impact on long journeys.